Market players in key import markets noted that ibuprofen prices continued to follow an upward trend. The market in the US was at the epicenter of this price movement in December 2025 and January 2026. Prices remained stable before rising in December as increasing API costs put pressure on importers. The US market, which relied heavily on imported API, especially from Asian sources, was sensitive to inflation in API costs. The rising costs of raw materials, intermediate chemicals, utilities, and regulatory compliance added to the cost of producing ibuprofen. These rising costs were passed down the supply chain, eventually leading to higher offer prices to buyers in US Logistics and freight costs, which remained high, helped to strengthen the bullish trend. These costs included transportation costs, insurance costs, and port risks, all of which remained high. This trend was maintained in January 2026 as well. In the coming days, it is predicted that the prices of ibuprofen will remain high due to supply-side factors and will not come down anytime soon.
